Search
Selected: M

Method for prolonging the inhibitory effect of saralasin on angi

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for promoting growth of new connective tissue over surfac

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for prophylaxis and/or treatment of sickle cell disease

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for prophylaxis and/or treatment of sickle cell disease

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for stimulating release of prolactin

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for the detection of viruses

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for the treatment of idiopathic headache attacks, in part

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for the treatment of systemic lupus erythematosus and pri

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for treating and preventing bacterial infections

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for treating glaucoma with topical or systemic ACE inhibi

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for treating pregnant females for pain and anxiety

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for treatment of psoriasis

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method for treatment of transplanted tumors in mice

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of control of gastrointestinal bleeding

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of controlling obesity with purified active principle of

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of diminishing glucose levels resulting from endogenous g

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of employing oral TRH

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of increasing immunologic competence

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of increasing oral absorption of polar bioactive agents

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Method of inducing analgesia

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.